SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
批准号:
1722614
负责人:
Turgay Ayer
金额:
$43.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2023-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chronic hepatitis C virus (HCV) infection is a global health problem that causes more deaths than other common infectious conditions, including HIV/AIDS, tuberculosis and malaria. Because the infection has a long latency period with few symptons, the majority of those infected remain unaware of their health status. The World Health Organization (WHO) and the National Academy of Medicine recently set an ambitious target to eliminate HCV by 2030; however, several challenges exist. The true prevalence of disease is unknown and effective screening policies do not exist, and treatment, while effective, is very expensive. This project has the following three overarching aims: 1) estimating the true disease burden of hepatitis C at the State and National level; 2) identifying effective screening and treatment strategies for identifying hepatitis C infection; and 3) designing practical decision support tools for use by stakeholders to manage the disease. From a societal perspective, the research will assist decision makers in reducing HCV disease burden. The team is engaged with the Centers for Disease Control and Prevention (CDC), State and County health departments, and the World Health Organization (WHO), who are the potential stakeholders of the research. This project will also provide learning and research experience to students and fellows on the application of systems dynamic modeling to healthcare.This research will apply methodologies from epidemiology and operations research to provide decision support for the allocation of limited resources to effective intervention policies to contain the ongoing epidemic of HCV. The research team will address several important research questions related to hepatitis C management and control by 1) conducting surveys to estimate HCV prevalence in at-risk populations; 2) estimating the true HCV prevalence at the State and National level via a validated agent-based simulation model; 3) researching optimization-based approaches to dynamic allocation of adaptive intervention strategies. The research is expected to lead to practical decision support. The research will advance knowledge in mathematical and computational modeling of infectious diseases and guide the allocation of limited resources towards eliminating HCV as a global health threat.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1001/jamanetworkopen.2019.3613
发表时间:
2019-05-01
期刊:
JAMA NETWORK OPEN
影响因子:
13.8
作者:
[Chhatwal, Jagpreet, Chen, Qiushi, Kanwal, Fasiha]
通讯作者:
Kanwal, Fasiha
Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning–Based Metamodeling: A Case of Hepatitis C Treatment
使用基于机器学习的元建模进行成本效益和信息价值分析:丙型肝炎治疗案例
DOI:
10.1177/0272989x221125418
发表时间:
2022
期刊:
Medical Decision Making
影响因子:
3.6
作者:
[McCandlish, John Austin, Ayer, Turgay, Chhatwal, Jagpreet]
通讯作者:
Chhatwal, Jagpreet
PDG32 GAME-THEORETICAL ANALYSIS OF NETFLIX PAYMENT MODEL FOR HEPATITIS C TREATMENT
PDG32 丙型肝炎治疗 Netflix 支付模型的博弈论分析
DOI:
10.1016/j.jval.2020.04.322
发表时间:
2020
期刊:
Value in Health
影响因子:
4.5
作者:
[Ayer, T., She, Z., Zhuo, Y., Chhatwal, J.]
通讯作者:
Chhatwal, J.
FEASIBILITY AND COST OF HEPATITIS C ELIMINATION IN CHINA
中国消除丙型肝炎的可行性和成本
DOI:
--
发表时间:
2019
期刊:
Hepatology
影响因子:
13.5
作者:
[Chhatwal, J, Zhuo, Y, Chen, Q, Zhan, T, Chen, W, Ayer, T, Nwankwo, C, Puenpatom, A]
通讯作者:
Puenpatom, A
DOI:
10.1136/bmjopen-2018-026726
发表时间:
2019-06-01
期刊:
BMJ OPEN
影响因子:
2.9
作者:
[Chen, Qiushi, Ayer, Turgay, Chhatwal, Jagpreet]
通讯作者:
Chhatwal, Jagpreet
共 8 条
RAPID: Collaborative Research: Mitigation and Suppression of Coronavirus Pandemic with Data-driven RAPID Decisions Using COVID-19 Simulator
-
批准号:2035360
-
项目类别:Standard Grant
-
资助金额:$9.2万
-
财政年份:2020
-
负责人:Turgay Ayer
-
依托单位:
SCH: EXP: Smart Adaptive Adherence-Enhancing Intervention Strategies for Breast Cancer Prevention
-
批准号:1601084
-
项目类别:Standard Grant
-
资助金额:$28.96万
-
财政年份:2017
-
负责人:Turgay Ayer
-
依托单位:
CAREER: Optimal Management of Chronic Diseases Caused by Infections
-
批准号:1452999
-
项目类别:Standard Grant
-
资助金额:$50.0万
-
财政年份:2015
-
负责人:Turgay Ayer
-
依托单位:
GOALI: Improving Blood Collection, Production, and Inventory Operations
-
批准号:1335137
-
项目类别:Standard Grant
-
资助金额:$36.0万
-
财政年份:2014
-
负责人:Turgay Ayer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内源性逆转录病毒MER65-int调控人类胎
盘发育与子宫内膜重塑的功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:屈雨亮
-
依托单位:
隐秘重组信号序列INT-RSS在T细胞受体基因Tcra重排中的功能和机制研究
-
批准号:32370939
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:郝冰涛
-
依托单位:
HPV16 E7 通过 Int1 蛋白调控 Wnt 信号通路调节肿瘤局部树突状细胞活性
-
批准号:LQ22H160033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈婷婷
-
依托单位:
选择性PPARγ激动剂INT131调控适应性产热和AD-MSCs分化成棕色样脂肪细胞的机制研究
-
批准号:81903680
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:高茸
-
依托单位:
INT复合物调节U snRNA 3'加工的结构基础
-
批准号:31800624
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2018
-
负责人:杭婧
-
依托单位:
沉默Int6基因的骨髓间充质干细胞复合生物支架构建血管化腹股沟疝补片及其促补片血管化机制
-
批准号:81371698
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:赵一麟
-
依托单位:
HIF/Int6调控迟发型EPC体外增殖的机制及其治疗重度子痫前期的可行性
-
批准号:81100439
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李勤
-
依托单位: